Segra International Corp, a Canadian agriculture technology company specialised in Cannabis plant tissue culture, is pleased to announce the closing of $6.0MM CAD in equity financing. The company intends to use the proceeds of the financing to drive continued innovation in plant tissue culture for the cannabis industry and to continue aggressive expansion of its sales networks across Canada and around the globe.
"This additional investment is a testament to our success in Segra's first eighteen months as a licensed operator, generating revenue through our suite of products. With one of the largest libraries of Cannabis cultivars in tissue culture globally, our customers look to us for access to true-to-type, Verified Clean Stock plantlets to mitigate the risks and challenges of large-scale cultivation and to meet evolving consumer demands. Segra has signed 50 agreements with Canadian and international cannabis companies since the start of 2020, all while our unparalleled research team continues to drive its innovation pipeline. This newest round of investment will allow Segra not only to continue to grow as a company but also to drive forward the future of how Cannabis is cultivated," says Jamie Blundell, Chief Executive Officer, Segra International.
Segra is an agriculture technology company offering plant tissue culture, genomics, DNA fingerprinting, and pathogen detection services to accelerate the advancement of the cannabis industry.
"Our proprietary technologies empower our clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices," they explain.
Segra has developed industrial-scale laboratories to produce Verified Clean Stock, robust, and DNA-fingerprinted Cannabis plantlets for licensed producers globally. To support this vision, Segra has assembled a team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance.